Cargando...
New biomarkers for checkpoint inhibitor therapy
Immune checkpoint inhibitor blockade has vastly changed treatment paradigms and improved outcomes of many solid organ malignancies. The achievements of the last decade have transformed the outcomes of several tumour types, most notably metastatic melanoma. There are, however, still large numbers of...
Gardado en:
| Publicado en: | ESMO Open |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7493090/ https://ncbi.nlm.nih.gov/pubmed/32933940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2019-000597 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|